The Global Cell And Gene Therapy Market is valued at USD 20.5 Billion in 2024 and is projected to reach a value of USD 128.8 ...

Students from North Point High School’s Academy of Health Professions and Biotechnology career and technical education (CTE) ...

Cultivarium, a non-profit bioengineering firm, announced today a three-year project to develop advanced tools for life ...

The resurrection of the dire wolf by Colossal Biosciences marks a fascinating intersection of popular culture and ...

Plant breeding plays a vital role in ensuring global food security by increasing crop yields, improving nutritional quality ...

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

Acoustic stimulation affects cell development and gene activity, revealing potential applications in biotechnology and ...

Twist Bioscience Corporation , a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced the expanded launch of the Twist High Throughput ...

Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.

Moffitt Cancer Center launches new podcast, The ImmunoVerse, where Patrick Hwu, MD, will discuss immunotherapy research with ...

Immunai will generate a publicly accessible multi-omic dataset for a Parker Institute cohort of over 1,000 cancer patients.